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Introduction
Micellar liquid chromatography (MLC) is a form of reversed-
phase liquid chromatography (RPLC) in which the mobile phase 
is an aqueous micellar solution whose concentration is above 
the critical micellar concentration (cmc) [1,2]. The most widely 
used surfactant in MLC is anionic sodium dodecyl sulfate (SDS); 
others include neutral Brij-35 and cationic N-cetyltrimethylam-
monium chloride. MLC is a highly versatile technique that ex-
ploits the great variety of interactions between solutes, micelles, 
and the stationary phase. It is therefore appropriate for the analy-
sis of a wide range of solute (hydrophilic and hydrophobic com-
pounds), which can be separated in the same run.
A common practice in the most developed MLC procedures 
is to add a small amount of an organic solvent, usually a short-
chain alcohol (methanol, propanol, butanol, or pentanol) or ac-
etonitrile, to the mobile phase [2,3], resulting in hybrid mobile 
phases. The presence of the organic solvent increases the elu-
tion strength and improves the shape of the chromatographic 
peaks. For the resolution of complex mixtures, it is also impor-
tant to properly adjust the pH of the mobile phase and to be 
aware of the acid-base side reactions of the solutes. Tempera-
ture and ionic strength should also be considered.
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Resum. En la cromatografia líquida micel·lar (MLC), la fase mò-
bil és composta per un surfactant i un alcohol. Els paràmetres 
que s’han d’optimitzar en la MLC són el tipus de columna, el 
pH, la naturalesa del surfactant i el modificador, i les seves con-
centracions. L’optimització es realitza utilitzant una estratègia 
interpretativa en la qual la millor fase mòbil se selecciona per a 
estudis de validació. Els mètodes optimitzats en MLC proporci-
onen separacions ràpides, eficaces, i permeten la determinació 
d’una gran varietat de substàncies en una matriu complexa. La 
MLC és una tècnica útil per a identificar medicaments en fluids 
biològics, que sovint es poden injectar directament al sistema 
cromatogràfic fins i tot en presència d’uns altres composts, in-
cloent-hi proteïnes, sense cap altre pretractament que la filtra-
ció. En descriure les moltes aplicacions de la MLC, aquesta re-
visió inclou exemples agafats de la literatura, i també resultats 
recents de la mateixa recerca dels autors. Descriu l’aproxima-
ció teòrica, l’estratègia d’optimització i les aplicacions de la 
MLC en la determinació de grups diferents de substàncies de 
medicaments. Els compostos i les matrius en discussió són els 
següents: antidepressius en farmacèutics, agents de blocatge 
de canal de calci en sèrum, anserina i carnosina en mostres de 
carns, tiramina i triptamina en vins, i sulfonamides en llet.
Paraules	clau:	cromatografia líquida micel·lar (MLC) · 
estratègies de modelització i optimització en MLC · 
aplicacions de MLC en química bioanalítica
Abstract. In micellar liquid chromatography (MLC), the mobile 
phase is composed of a surfactant and an alcohol. The param-
eters that must be optimized in MLC are the type of column, 
the pH, the nature of the surfactant and modifier, and their con-
centrations. Optimization is performed using an interpretive 
strategy in which the best mobile phase is selected for valida-
tion studies. Optimized methods in MLC provide fast, efficient 
separations, thereby allowing the determination of a great vari-
ety of substances in a complex matrix. MLC is a useful tech-
nique for the identification of drugs in biological fluids, which 
often can be injected directly into the chromatographic system 
even in the presence of other compounds, including proteins, 
without any pretreatment other than filtration. In describing the 
many applications of MLC, this review draws upon examples 
taken from the literature as well as recent results of the authors’ 
own research. It describes the theoretical approach, optimiza-
tion strategy, and applications of MLC in the determination of 
different groups of drug substances. The compounds and ma-
trices under discussion are: antidepressants in pharmaceuti-
cals, calcium-channel blocking agents in serum, anserine and 
carnosine in meat samples, tyramine and tryptamine in wines, 
and sulfonamides in milk.
Keywords: micellar liquid chromatography (MLC) · modeling 
and optimization strategies in MLC · MLC applications in 
bioanalytical chemistry
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This review begins by describing the optimization strategies 
used in MLC [1,17,18,22]. The development of a micellar ana-
lytical procedure for the determination of solutes in pharma-
ceuticals and biological fluids requires optimization of the col-
umn type, the type and concentration of the surfactant and 
organic modifier, pH, flow rate, and temperature. In addition, 
the optimization strategy can be sequential or interpretive. In 
a sequential strategy, a set of mobile phases is designed by 
taking into account the retention observed with previous elu-
ents (the retention of the solutes is not known a priori). When 
the experiments are designed before the optimization process 
and used to fit a model that will allow the retention of each sol-
ute to be predicted, the strategy is called interpretative, and, of 
the two, it is more efficient and reliable. The need for an ade-
quate experimental design becomes especially important 
when dealing with forms of liquid chromatography suitable for 
the simultaneous analysis of ionic and non-ionic compounds, 
such as MLC, in which several factors should be controlled. 
The strategy used to develop the method must provide an-
swers to questions concerning the variables to be used as well 
as the set-up of the initial experiments that will yield an effective 
search of the appropriate variable space.
The second part of this review discusses the methodology 
used to develop a procedure for the control of several com-
pounds in pharmaceutical, urine, serum, and food samples 
[9,13,14,19,21]. In RPLC, the determinations of a given family of 
substances are normally carried out either by isocratic elution 
with mobile phases of diverse composition or, if the polarity of the 
compounds is wide, by gradient elution. In the analysis of phar-
maceuticals, however, the use of a unique mobile phase contain-
ing different drugs of diverse polarities is an attractive option.
Pharmaceutical formulations are commercially available in 
several forms (capsules, creams, drops, enemas, oily injections, 
ointments, pills, solutions, sprays, suspensions, syrups, and 
tablets). One of the main advantages of MLC in the resolution of 
mixtures of substances of different polarities is that the addition 
of just a small amount of an organic modifier to the mobile 
phase obviates the need for gradient elution [5,11,12]. 
Beyond the determination of drugs in biological fluids 
[2,3,6,7,13,18–20], MLC is a useful technique for the detection 
of compounds in food samples [14,21], which can be injected 
directly into the chromatographic system even in the presence 
of other compounds, including proteins. Moreover, as pointed 
out in this review, in MLC a single mobile phase is able to re-
solve several compounds of interest from complex mixtures, 
biological fluids (serum and urine), and food samples.
Modeling	and	optimization	in	MLC
Modeling	of	the	retention	behavior.	The retention by SDS-
modifier mobile phases can be modeled empirically (Eqs. 1–5) 
or mechanistically (Eqs. 6–9) [22] using the retention data of 
only five to eight mobile phases. Efficiency and asymmetry fac-
tors are also used to fit some of the equations.
In Equation 1, solute retention is linearly related to the mo-
bile-phase variables within a selected portion of the optimiza-
tion space and is fitted to a separate, logarithmic linear func-
tion.
 log k = c0+ c1[M]+ c2{ (1)
Equation 2 establishes the hyperbolic relationship between 
retention and a fixed amount of organic solvent.
 
k
1 = c0+ c1[M] (2)
Equation 3 models the retention of a solute at varying con-
centrations of both the surfactant and the modifier.
 
k
1 = c0+ c1[M]+ c2{ (3)
Other empirical equations describe the retention behavior of 
any surfactant and organic solvent content [13,14,19] by con-
sidering the log k or 1/k values related to the micellar concen-
tration and the volume fraction of the organic modifier. Loga-
rithmic models usually yield poorer results. Equation 4 is the 
simplest equation that provides good predictions for both polar 
and moderately polar compounds, such as amino acids, anti-
depressants, biogenic amines, b-blockers, sulfonamides, and 
diuretics. This equation yields linear plots of 1/k vs. { at fixed 
concentrations of the surfactant.
 
k
1 = c0+ c1[M]+ c2{+ c3[M]{ (4)
For highly hydrophobic compounds, Equation 4 plots are 
non-linear and an additional term is required, as shown in 
Equation 5.
 
k
1 = c0+ c1[M]+ c2{+ c3[M]{+ c11{2 (5)
The parameters in Eqs. 4 and 5 should be obtained by fitting 
the data in experimental designs with at least four and five mo-
bile phases, respectively. However, at least one additional 
measurement should be made to check the accuracy of the 
fittings. The predictions obtained with Eqs. 1–3 are not accu-
rate enough whereas the prediction errors of Eqs. 4 and 5 are 
usually <3% [5,11,21]. The parameters of the empirical MLC 
models are related to the physicochemical constants describ-
ing the interactions of the solutes with the three environments 
of micellar mobile phases: bulk water, micelles, and the sta-
tionary phase. A better understanding of the retention mecha-
nism in micellar systems is provided by these models. Mecha-
nistic models are based on Equation 2, which is the classical 
equation proposed for micellar mobile phases at a fixed volume 
fraction of organic modifier. Equation 2 can be re-written as 
Equation 6, which relates the retention of a solute to the con-
centration of monomers of the surfactant in the form of mi-
celles.
 k = 1+ KAM [M]
KAS  (6)
For SDS-modifier micellar mobile phases, Equation 6 can be 
expressed as shown in Equation 7 [12], and Equation 5 as 
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shown in Equation 8. In the latter equation, retention may as-
sume an excessive dependence on { and produce high errors 
when an extrapolation is made in a region of high modifier con-
centration.
 k =
1+ KAM 1+ KAD{
1+ KMD{ [M]
KAS 1+ KAD{
1
 (7)
 k =
1+ KAM 1+ KAD1{+ KAD2{2
1+ KMD{ [M]
KAS 1+ KAD1{+ KAD2{2
1
 (8)
Equation 9 was proposed as an alternative model for highly 
hydrophobic solutes that takes into account the additional 
change in the concentration of solute associated with the sta-
tionary phase produced by the presence of modifier [12]. The 
constants KMD and KAD describe the displacement of the wa-
ter-micelle equilibrium, while KSD and KAD represent modifica-
tion of the water-stationary phase equilibrium.
 k =
1+ KAM 1+ KAD{
1+ KMD{ [M]
KAS 1+ KAD{
1+ KSD{
 (9)
Equation 9 accurately describes the retention of solutes 
characterized by a wide range of polarities and eluted in SDS-
modifier mobile phases [2].
Modeling	of	 the	peak	profile.	 In MLC, an increase in the 
SDS concentration usually lowers the efficiency. Overall, MLC 
separations are characterized by a lower chromatographic ef-
ficiency than those achieved with aqueous-organic chroma-
tography. Consequently, the equations describing the peak 
profiles are more complex. In MLC, the best peak-profile pre-
dictions are achieved using a Gaussian equation [1] in which 
the standard deviation depends polynomially on the distance 
to the peak time (Equation 10).
 h (t) = H0e-0.5 s0+s1(t- tR)+s2(t- tR)2+ ...
t- tRe o
2
 (10)
where h(t) is the predicted signal at time t, H0 the maximal peak 
height, tR the retention time, and the coefficients si are related 
to the width and asymmetry of the chromatographic peak. For 
a given solute and mobile phase, tR and si are ideally invariable, 
whereas H0 depends on the concentration. This equation is 
also useful for graphical simulation of the chromatograms.
Modeling	of	peak	resolution. In chromatography, the most 
widely extended optimization criteria to depict chromatograph-
ic performance are based on the calculation of an individual or 
elementary resolution measurement, ri, for the least-resolved 
peak or peak pair, where p is the number of peaks or peak 
pairs and R is the global resolution (Equation 11).
 R = MIN (ri) 1 ≤ i ≤ p (11)
These criteria are combined in MLC with the un-normalized 
product of Equation 11 and seem to be a better approach, al-
though it can only be used with intrinsically normalized resolu-
tion measurements. This product varies from 0 (complete over-
lap between at least two peaks) to 1 (full resolution of each peak 
in the chromatogram). The global resolution function is com-
bined with the elementary resolution as peak-to-valley meas-
urements (Equation 12) and as overlapping fraction measure-
ments (Equation 13) [11].
 ri, i+1= 1- h2
h1  (12)
 ri, i+1= 1- oi
oi
'
 (13)
where h1 represents the height of the signal at a specific time to 
depict the valley location, h2 is an interpolated height, meas-
ured at that time from the baseline to the line obtained by join-
ing the maximums of the two neighboring peaks, oi’ is the area 
under a given peak overlapped by the chromatogram obtained 
from the remaining peaks, and oi is the total area of the peak.
These strategies combined with computer analysis allow the 
simulation of chromatograms to predict peak retention and 
peak profile as accurately as possible [1]. The reliability of these 
simulations, assessed for different groups of compounds by 
comparing experimental and predicted chromatograms 
[3,5,6,11,20,21], is confirmed by the adequately low rate of er-
rors. Thus, the mobile phase can be optimized and selected 
using this chemometric approach.
Determination	of	drugs	in	pharmaceutical	
formulations
Column	selection.	The most widely used columns in MLC are 
of the C18 type but, depending on the substances to be sepa-
rated, other columns can be considered. The amount of sur-
factant adsorbed in the stationary phase has important implica-
tions regarding the retention behaviors of the solutes. Adsorption 
isotherms of SDS have shown that the amount of surfactant ad-
sorbed by C8 columns is lower than that by C18 columns. Ad-
sorption curves increase rapidly and reach a plateau at an SDS 
concentration higher than its cmc, which is 8.2 mM. For C18 
columns, the adsorbed amount is constantly above the cmc, but 
for C8 columns the plateau is only reached at 300 mM SDS. The 
amount of SDS in the bonded phase is even lower for cyano-type 
columns and increases to at least 400 mM SDS with increases in 
the concentration of surfactant in the mobile phase [1].
pH	selection.	The pH is the first parameter to be considered 
in optimizing the composition of the mobile phase. For most 
columns, including C18-, C8-, and cyano-types, the working 
pH is restrained within a range of 3–9. Protonated substances 
interact with the negative charge of SDS, which increases their 
retention. For this reason, it is important to consider the proto-
nation state of substances under study.
For anticonvulsants [16], benzodiazepines, and related 
compounds [17], a pH of 3 is appropriate based on the chemi-
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cal properties of the substances. It is adequate when com-
pounds are hydrophilic but can be positively charged, as is the 
case for b-blockers, carbamates, furosemide, and the vitamin 
B group [8,10]. The stability of the compounds at pH 3 is an-
other factor to be considered. When the substances under 
study do not show an acid-base behavior or any other advan-
tage at pH 3–9, pH 7 is preferred in order to extend column life.
Use	of	SDS	and	other	surfactants.	For pure micellar mobile 
phases, i.e., in the absence of any organic modifier, the chro-
matographic parameters, such as retention factors, asym-
metries, and efficiencies, usually decrease as the surfactant 
concentration increases.
The most widely used surfactant in MLC is SDS (C12H25OSO3
Na), an anionic surfactant belonging to the alkyl sulfate group. 
An important property of surfactant solutions is that they form 
micelles at a concentration above the cmc. For SDS, with a 
cmc of 8.2 mM, the aggregation number (NA) is about 70 mon-
omers of surfactant per micelle at 25ºC.
Organic	modifier	selection.	Most analytical procedures in 
MLC require the addition of a short-chain alcohol such as pro-
panol, butanol, or pentanol, as its presence increases efficien-
cies. In SDS-modifier micellar mobile phases, the retention 
factor decreases as the modifier concentration increases, in-
fluencing the selectivity of the method. The proper selection of 
an alcohol is related to the polarity of the substances to be ana-
lyzed: propanol is useful for the most polar compounds, while 
pentanol improves the separation of hydrophobic substances.
It should be noted that very high efficiencies (3000–7000) 
have been obtained with hybrid mobile phases of SDS-butanol 
and SDS-pentanol. The upper reported efficiency values in 
MLC were generally below 4000. However, in the concentra-
tion ranges that were studied (50–150 mM for SDS, 3–6% (v/v) 
for butanol; 2–5% (v/v) for pentanol), the changes in retention 
produced by a change in the SDS concentration were higher 
than those produced by the modifier when butanol was used 
while pentanol displayed the opposite behavior.
Compared to RPLC methods employing aqueous-organic 
mobile phases, micellar mobile phases have the advantage of 
using small amounts of an organic modifier. Furthermore, pro-
panol, butanol, and pentanol are retained in the micellar solu-
tion of SDS, thus reducing the risk of evaporation and increas-
ing the stability of the micellar mobile phases. In addition, these 
alcohols are less toxic than methanol or acetonitrile, which are 
used in conventional RPLC.
Drug	derivatization.	The injection of sulfonamides into micel-
lar mobile phases results in their appearance near the void vol-
ume, owing to their low hydrophobicity. Thus, to separate 
these substances using MLC, they must first be derivatized 
[21], e.g. using the Bratton-Marshall reagent, N-1-napthyl-eth-
ylenediamine dihydrochloride (NED), as was the case in the 
study described in the following. To form the derivatives, sul-
fonamides are diazotized and coupled (Fig. 1). The azo dyes 
thus produced have a higher retention rate, thus enhancing the 
selectivity of the MLC method. Moreover, the resulting shift of 
the drug absorption bands to longer wavelengths upon deriva-
tization facilitates their detection.
Method	validation
One of the most critical factors in developing a chromato-
graphic procedure to analyze pharmaceuticals is to ensure that 
the HPLC analytical test generates meaningful data. The Inter-
national Conference on Harmonization Guidelines has intro-
duced steps that must be taken in experimental work to define 
the appropriate validation characteristics; these may be con-
sidered simultaneously in the analytical procedure. They in-
clude, for instance, specificity, linearity, range, accuracy, and 
precision. Calibration graphs are usually constructed by at 
least a triplicate injection of five solutions of the drugs at in-
creasing concentrations. Calibration curves are obtained by 
measuring the peak areas of each drug eluted with the opti-
mum micellar mobile phase. Linear regression coefficients are 
usually r > 0.999. Limits of detection (LODs) are calculated us-
ing the 3s criterion, which corresponds to a signal equal to 
three times the standard deviation of the background noise, 
i.e., the signal-to-noise ratio is equal to 3. LODs are usually be-
low those required for the analysis of pharmaceuticals. Repeat-
ability, or intra-assay precision, is determined using an average 
of ten measurements made on the same day. Intermediate 
precision is the average of ten repeatability measurements tak-
en on 10 days over a 3-month period by different analysts, 
equipment, etc., and at three different drug concentrations in 
the range of the calibration graph.
Final validation of a MLC procedure aimed at determining the 
presence of pharmaceutical compounds includes a compari-
son of reference conventional RPLC with aqueous-organic mo-
bile phases, to confirm the competitiveness of the latter. The 
performances of RPLC in the analysis of samples of two chro-
matographic modes should be compared, e.g., by injecting an-
drogens and anabolic steroids [4] or sulfonamides [21] as drugs.
Two RPLC procedures using hydro-organic (11% acetonitrile) 
and micellar-organic (45 mM SDS-6% (v/v) acetonitrile) mobile 
phases were developed for the analysis of ten pharmaceutical 
formulations containing sulfacetamide, sulfadiazine, sulfaguani-
dine, sulfamethazine, sulfamethizole, sulfamethoxazole, or sul-
fathiazole. The composition of the selected mobile phases, for-
mulated using algorithms, was determined using a classical 
empirical model for conventional RPLC and a mechanistic mod-
el for micellar RPLC. The two mobile phases were compared 
H R
N
SO2
NH2
NaNO2
pH = 1
H R
N
SO2
N≡H+
NED
NH CH2-CH2-NH2
N=N SO2 N
H
R
Fig.	1. Derivatization and coupling reactions for the UV determination 
of several compounds. (Reproduced with the permission of Elsevier 
[21]).
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with respect to determination of the drugs in pharmaceuticals 
the calibration curves, and the LODs, with the latter two being 
similar for the two cases. The determination of sulfaguanidine 
was the most problematic in the hydro-organic mode due to the 
low retention time of the compound. Nonetheless, the results 
showed that MLC is a competitive technique compared to con-
ventional RPLC. Added advantages of MLC are the reduction in 
the amount of acetonitrile–in compliance with the increasing re-
strictions placed on the use of organic solvents in laboratories–
and the use of cheaper and less toxic mobile phases.
Sample	pretreatment	in	MLC
Conventional analytical aqueous-organic procedures can be 
replaced by those using micellar eluents in the control of phar-
maceutical preparations, with good results. MLC offers impor-
tant benefits over conventional RPLC; for example, a drug so-
lution can be injected into the chromatographic system without 
the need for any treatment other than filtration, thus reducing 
sample preparation time. Although excipients are frequently 
not soluble in micelles, drugs are easily extracted when sam-
ples are treated with micellar solutions. The solubility of drugs is 
improved by the addition of a small amount of alcohol (metha-
nol or ethanol) into the micellar media. The chromatograms of 
the pharmaceuticals show a peak in the void-volume region 
that corresponds to the excipients and to other compounds 
that are only retained to a slight extent (Fig. 2).
Sample preparation is very simple and depends on the phar-
maceutical formulation: solids (capsules, tablets, pills, and pow-
ders), liquids (drops, solutions, suspensions, sprays, oily injec-
tions, syrups), ointments, and creams. In the case of solids, ten 
tablets or pills are weighed, ground to a fine powder, and homog-
enized. Several portions of this powder are selected, weighed 
and then dissolved with a suitable mobile phase. For capsules 
(typically, 10 units) are carefully emptied and cleaned and their 
contents weighed. With powders, the contents of 10 packets are 
mixed, homogenized, and the same procedure as used with tab-
lets is then followed. For liquids, pretreatment is simpler and con-
sists of homogenizing three aliquots, each of which is later mixed 
with a small amount of alcohol and diluted with a micellar solu-
tion. For more complex samples, such as ointments and creams, 
1–2 g are mixed with the hybrid micellar solution, usually the mo-
bile phase. If the sample contains high concentrations of fat-solu-
ble excipients, an emulsion is formed in which case more hybrid 
micellar solution is added to further dilute the sample and to ob-
tain a clear solution for analysis. The process is facilitated by the 
use of mechanical stirring and an ultrasonic bath. The recoveries 
obtained usually agree with the compositions declared by the 
manufacturers within the tolerance limits. Sample preparation 
time is shorter in MLC than in conventional procedures, which 
usually entail long and tedious extraction steps.
In drug determination of biological fluids such as serum and 
urine by MLC, the sample can be injected directly, without any 
pretreatment. SDS micelles tend to bind proteins competitively 
by releasing protein-bound drugs. Therefore, substances are 
free to partition into the stationary phase, and proteins are sol-
ubilized rather than precipitating into the column, eluting with, 
or shortly after, the solvent front.
Serum to be used for MLC analysis only needs to be centri-
fuged at speeds of 1400–3000 rpm for 10 min, which quickly 
separates serum from blood. Urine can be directly injected. 
Serum and urine are filtered before being introduced into the 
separation vial. When serum is injected into the chromato-
graphic system, a wide band of proteins as well as several 
peaks corresponding to endogenous compounds appear at 
the beginning of the chromatogram, which could affect the de-
tection of less retained substances (Fig. 3). The injection of a 
large number of serum or urine samples will shorten the life of 
the column or will require frequent regeneration of the station-
ary phase to avoid changes in the retention times due to matrix 
adsorption. To decrease the width of the protein band, serum 
and urine samples are diluted with a 0.9% NaCl solution.
Solid food samples, like meat, should first be ground finely 
using a mincer at 5000 rpm for 5 min and the homogenized 
sample then mixed with surfactant solution, followed by con-
tinuous shaking for 15 min. Afterwards, the homogenate is 
centrifuged at 3000 rpm for 5 min and the supernatant filtered 
and diluted in a SDS solution before its direct injection into the 
chromatographic system. Liquid food samples, such as milk, 
0.00 4.00 8.00 12.00 16.00
Fig.	2. Chromatogram showing the determination of a quinolone in a 
pharmaceutical.
A) B)
201612
Time (min)
840201612
Time (min)
840
Fig.	3. Micellar liquid chromatograms in which the serum (A) and urine 
(B) blanks have been directly injected into the chromatograph.
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can be directly injected into the chromatograph as described in 
the previous section for physiological samples.
There are some special cases, for example, sulfonamides 
[21], which prior to being injected are derivatized to improve 
selectivity, as discussed above. Sulfonamides are arylamines 
and contain a primary aromatic amine. This feature can be ex-
ploited in a diazotization-coupling reaction, as the resulting azo 
dyes can be detected and quantified in the visible band. Deri-
vatization consists of three steps: (1) diazotization with sodium 
nitrite, (2) the elimination of excess sodium nitrite through reac-
tion with sulfamic acid, and (3) coupling with the Bratton-Mar-
shall reagent (NED). The use of a micellar SDS-containing me-
dium offers several advantages, including alleviating the need 
to alter the pH, lowering the reaction time, and enhancing the 
molar absorption of the azo dyes.
MLC	applications	in	bioanalytical	chemistry
Antidepressant	in	pharmaceuticals	and	urine.	Trazodone 
(TRZ) is a psychoactive compound that belongs to the group of 
second-generation non-tricyclic antidepressants used to re-
lieve symptoms of depression. TRZ has been determined in 
pharmaceutical formulations and in urine samples [9]. Since 
the drug has a relatively low absorption in the UV region, spec-
trofluorimetric detection based on the native fluorescence of 
TRZ in SDS was implemented, with mexc = 325 nm and mem = 
440 nm. In the following study, the optimized procedure con-
sisted of a C18 column and a micellar mobile phase of SDS 
and 1-butanol. The mobile phase selected for use was 0.2 M 
SDS and 8% 1-butanol, with a pH fixed at 3 with phosphate 
buffer. The total analysis time was 10 min. Calibration in the 
TRZ pharmaceutical formulation was studied in the range of 
0.3–5 µg/ml, yielding a good regression coefficient (r > 0.999) 
and good claim percentages (100.8–101%). The values agreed 
well with those declared by the manufacturer. 
For the analysis of TRZ in urine, one main advantage is that 
samples do not require an extraction step. Calibration repeat-
ability for the urine matrix was studied in at concentrations of 
0.06–22.4 µg/ml, showing good linearity (r > 0.9991). The quan-
tification limit was 9.5 ng/ml, thus ensuring the analysis of TRZ 
in biological fluids. The procedure showed good accuracy, re-
peatability, and selectivity. Repeatability and intermediate pre-
cision were tested for several concentrations of the drug, with 
high precision values (<2%). Good recoveries (93–110%) were 
obtained from spiked urine samples. No interferences from 
common additives frequently administered with TRZ or from 
endogenous compounds in urine samples were detected. The 
results were obtained with the optimized MLC method using 
samples collected from patients 6 h after TRZ administration 
(Deprax, 100 mg TRZ) (Fig. 4). In conclusion, this procedure is 
suitable for routine analyses of the drug.
Calcium-channel-blocking	agent	in	urine	and	serum.	Vera-
pamil [19] is determined in serum and urine samples by a sensi-
tive and precise chromatographic procedure, without any pre-
treatment step, using fluorescence detection set at 230 nm 
(excitation) and 312 nm (emission). Verapamil is a phenyla-
lkylamine derivate with calcium-channel-blocking activity. It is 
one of the most commonly prescribed drugs for the treatment of 
hypertension. Chemically, it is basic (log K = 9.1) with an equilib-
rium between two forms, one that is molecular and another that 
is positively charged. In the normal pH working range of C18 col-
umns (3–7), the positively charged form of verapamil is predomi-
nant, with no changes in the retention behavior. In addition, vera-
pamil is a highly hydrophobic compound (log Po/w = 4.6), such 
that the use of C18 columns and pure micellar mobile phases of 
SDS retention would be inappropriate. The mobile phase finally 
used to perform the analysis was 0.15 M SDS and 5% pentanol 
at pH 7. These conditions allowed the drug to be quantified in an 
adequate analysis time (12.5 min) without any interference by ei-
ther the protein band or endogenous compounds.
Linearities were studied within a range of 100–2000 ng/ml in 
three different matrices (micellar solution, serum, and urine), 
and the regression coefficients were consistently r > 0.998. In-
tra- and inter-day precisions were also studied in the validation 
method. The LODs were 11.0, 18.5, and 20.2 ng/ml in micellar 
solution, serum, and urine, respectively. Recoveries in the bio-
logical matrices were 97–99%. Drug excretion in urine was 
studied in a volunteer receiving treatment for hypertension, and 
verapamil, as an unchanged drug, was separated from other 
metabolites (Fig. 5). The final quantity of verapamil eliminated 
was 5.04 mg, i.e., 2.8% of the dose taken. These results sup-
port the use of this procedure in the field of toxicology and 
clinical analysis.
Imidazole	dipeptides	in	meat.	The imidazole dipeptides an-
serine and carnosine [14] are well-studied natural antioxidants 
that are present in some types of meat. Interest in these com-
Metabolite
Metabolite
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Fig.	4. Chromatogram of urine sample from a patient 6 h after the ad-
ministration of the trazodone (TRZ) formulation Deprax, containing 100 
mg of the active compound. (Reproduced with the permission of Else-
vier [9]).
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pounds in the area of food research derives from published 
studies of luncheon meats in which the meat species in proc-
essed meat products and the species incorporated into meat 
products were identified.
Three types of stationary phases (C18, phenyl, and amino 
columns) were examined at three different pH values (3, 5, and 
7) in a procedure designed to determine anserine and carnos-
ine in meat samples. Column performance was evaluated in 
terms of retention factor (k), efficiency (N), and peak asymmetry 
(B/A). The C18 column showed the highest retention at pH 3 
(k = 42.3 for anserine and k = 53 for carnosine) and the worst 
resolution at pH 7. Efficiencies were N = 300–1000 and 200–
600 for the phenyl and C18 columns, respectively. The quality 
of the chromatograms improved considerably when the amino 
column was used, with efficiencies and peak asymmetries of N 
from 1000 to 2600 and B/A from1.1 to 1.4. The two com-
pounds were completely resolved without any interference 
from the protein band, thus confirming that the amino column 
is the most appropriate stationary phase for further study.
The retentions of anserine and carnosine decreased when 
the pH of the mobile phase increased. At pH 7, complete reso-
lution and the lowest retention were achieved for both com-
pounds. A pure MLC procedure was developed using a micel-
lar mobile phase of 0.10 M SDS buffered at pH 7 and was 
followed by UV detection at 210 nm, with an analysis time of 
<12 min. The chromatographic parameters studied in this se-
lected mobile phase were retention factor, efficiency, and 
asymmetry. The values obtained for carnosine and anserine 
were 8.9, 1939, 0.95 and 10.3, 1760, 1.1, respectively.
Several validation characteristics were tested. Calibration 
curves were constructed in the 1–50 μg/ml range on three dif-
ferent days (r > 0.998). The limits of detection (ng/ml) were 71 
for anserine and 53 for carnosine. Repeatability and intermedi-
ate precision were evaluated at three different concentrations 
(1.5, 20, and 50 μg/ml) in meat matrices, with the residual 
standard deviations being <2.1%. In the evaluation of selectivi-
ty and recovery, recoveries values were around 100% without 
any interference from the protein band.
Meat samples (poultry, pork, and beef) were injected directly 
into the chromatographic system after extraction in a SDS solu-
tion followed by filtration (Fig. 6). The possibility of direct injection 
using MLC reduces costs and analysis time, in addition to de-
creasing error sources owing to minimized risks of losses and 
chemical changes in the analytes. Moreover, the selection of a 
pure mobile phase of SDS confers the procedure with a number 
of advantages over aqueous-organic solvent approaches, such 
as non-toxicity, non-flammability, biodegradability, and low cost. 
Its simplicity, therefore, makes it a good candidate for routine 
analyses in the area of food control and quality.
Biogenic	amines	in	wines. Two biogenic amines [13], tryp-
tamine (TryptA) and tyramine (TyrA), and their precursors, tryp-
tophan (TryptO) and tyrosine (TyrO), were determined in wine 
by a liquid chromatographic procedure. Increased levels of bio-
genic amines in foods are of interest from several points of 
view, including the fact that at high concentrations they cause 
direct or indirect toxicity. Once these compounds are formed, 
they are difficult to destroy by pasteurization processes or 
cooking. Accordingly, it is important to control the production 
process. In fact, some countries have established regulations 
regarding intake limits or maximum overall limits of biogenic 
amines in various foods.
A hybrid micellar mobile phase of SDS and 1-propanol was 
used with a C18 column and electrochemical detection. A pH 
study in the range of 3–9 was performed, and pH 3 was finally 
selected based on the resolution and the analysis time. Oxida-
tion potential at 0.6–0.9 V was also checked, with a maximum 
area obtained at 0.8 V. This potential was therefore selected for 
the subsequent analysis using a sequence pulsed amperomet-
ric detection waveform. The four compounds were resolved 
using a mobile phase of 0.15 M SDS and 5% 1-propanol, with 
an analysis time of 16 min. 
Calibration curves were constructed using increasing con-
centrations in the 0.1–10 μg/ml range, with a linear response 
(r > 0.996). Repeatabilities and intermediate precision were 
evaluated at three different concentrations (1, 3, and 10 μg/ml) 
for each compound, yielding RSD values lower than 2.6 and 
4.8%, respectively. LOD and quantification were obtained 
within the 10–40 and 33–135 ng/ml ranges, respectively. The 
applicability of the procedure was then tested in several types 
of wines and no matrix effect was observed (Fig. 7). These re-
sults show that direct sample introduction simplifies and great-
ly expedites these types of procedures, reducing their cost and 
improving their accuracy.
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Fig.	 5. Chromatograms of verapamil (VR) excreted in urine as un-
changed drug 4 h after oral ingestion (A), and of residual verapamil (B). 
(Reproduced with the permission of Elsevier [8]).
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Fig.	6. Chromatograms of (A) a minced beef sample diluted 1:10 and 
(B) a chicken and turkey hamburger sample diluted 1:1. A, Anserine, C 
carnosine. (Reproduced with the permission of Elsevier [14]).
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Sulfonamides	in	milk.	Sulfonamides [21] are widely used for 
the prevention and control of a number of veterinary diseases, 
such as gastrointestinal and respiratory infections, as well as 
for growth-promoting purposes and prophylactically. Inappro-
priate abusive antibiotic-based treatments can result in unde-
sired, persistent residues in animal tissues and in biofluids, in-
cluding milk. Consequently, to prevent health problems the 
European Community has adopted a maximum sulfonamide 
residue level of 100 μg of total sulfonamides kg-1 in edible ani-
mal tissue, including milk. Therefore, a simple method to iden-
tify and determine six sulfonamides (sodium sulfacetamide, 
sulfamethizole, sulfaguanidine, sulfamerazine, sulfathiazole, 
and sulfamethoxazole) in milk by MLC was developed.
In the assay pre-column, diazotization-coupling was carried 
out as described above. Separation was achieved using 0.08M 
SDS and 8.5% 1-propanol at pH 7. The analysis times were 
<16 min and resulted in complete resolution (Fig. 8).
Good linearities (r > 0.9999) were obtained using calibration 
curves in the range of 0.2–20 μg/ml. The limits of detection and 
quantification were approximately 0.72–0.94 and 2.4–3.1 ng/ml, 
respectively. The detection limit was below the maximum resi-
due limit established by the European Community. Intra- and 
inter-day precisions at three different drug concentrations (0.4, 
6, and 17.5 μg/ml) were < 3.7%. Recoveries in spiked milk 
samples (0.4, 6, and 17.5 μg/ml) were 83–103%. The results 
demonstrate that this procedure is useful to screen and quan-
tify sulfonamides in milk for routine analyses in the area of food 
control and quality.
Conclusions
This review of MLC described the optimization strategy used to 
select the best mobile phase for the resolution and determina-
tion of compounds in pharmaceutical preparations, serum, 
urine, and food samples. Compared to other eluents, micellar 
mobile phases are less flammable, cheaper, non-toxic, biode-
gradable, and can co-solubilize hydrophobic and hydrophilic 
analytes in complex matrices. In MLC, the elution of hydropho-
bic and hydrophilic analytes in the same run is possible without 
gradient elution. Furthermore, direct injection of physiological 
samples is feasible owing to the solubilization of proteins by the 
micelles and monomers of the surfactant. Additional features 
of this method are the possibilities of on-line analyte concentra-
tion and the ease with which selectivities can be changed by 
applying various separation additives. The pros and cons of 
MLC were outlined, and examples of the technique’s applica-
tion provided. Trends in MLC are quantitative structure–activity 
relationships (QSAR) studies, the mathematical description of 
mixtures of surfactants or modifiers, and the direct injection of 
bioanalytical samples.
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Fig.	7. Chromatograms of commercial wines: white (A), rosé (B), and red (C). (Reproduced with the permission of Elsevier [13].)
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Fig.	 8. Chromatograms obtained from milk samples: (A) blank milk 
treated with the diazotization-coupling reagents, with the azo-dye visu-
alized at 490 nm; (B) milk spiked with 25 ng/ml of each sulfonamide. 
Sulfonamides and retention times (min) were: (1) sodium sulfaceta-
mide, 4.5, (2) sulfamethiazole, 5.0, (3) sulfaguanidine, 7.0, (4) sulfam-
erazine, 9.9, (5) sulfathiazole, 11.6, and (6) sulfamethoxazole, 13.2. 
(Reproduced with the permission of Elsevier [21].)
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